Galectin Therapeutics Inc SEC filings GALT

Galectin Therapeutics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Oct 18, 2011. Its latest annual report, Form ARS, was filed on Oct 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Galectin Therapeutics Inc SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 4, 2026 —
4 Insider transaction Aug 4, 2026 Jul 31, 2026
4 Insider transaction Jul 16, 2026 Jul 14, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 25, 2026 Jun 23, 2026
144 Notice of proposed sale Jun 23, 2026 —
4 Insider transaction May 28, 2026 May 26, 2026
4 Insider transaction Mar 17, 2026 Mar 12, 2026
3 Initial insider ownership Mar 17, 2026 Mar 12, 2026
4 Insider transaction Feb 9, 2026 Feb 6, 2026
4/A Form 4/a Jan 22, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 13, 2026 Jan 5, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 6, 2026 —
144/A Filing Jan 5, 2026 —
4 Insider transaction Jan 5, 2026 Dec 31, 2025
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Dec 31, 2025 —
4/A Form 4/a Dec 23, 2025 Dec 23, 2025
4/A Form 4/a Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 18, 2025 Nov 24, 2025
144 Notice of proposed sale Dec 17, 2025 —
144 Notice of proposed sale Dec 17, 2025 —
144 Notice of proposed sale Dec 17, 2025 —
4 Insider transaction Dec 16, 2025 Dec 12, 2025
144/A Filing Dec 15, 2025 —
144 Notice of proposed sale Dec 15, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
4 Insider transaction Dec 10, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 9, 2025 —
144 Notice of proposed sale Dec 8, 2025 —
4/A Filing Dec 8, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 13, 2025 —
4 Insider transaction Nov 12, 2025 Oct 22, 2025
4 Insider transaction Nov 12, 2025 Nov 10, 2025
4 Insider transaction Nov 12, 2025 Nov 10, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
5 Annual insider ownership Oct 10, 2025 Dec 31, 2024
4 Insider transaction Sep 15, 2025 Sep 12, 2025
4 Insider transaction Sep 15, 2025 Sep 12, 2025
144 Notice of proposed sale Sep 12, 2025 —
144 Notice of proposed sale Sep 12, 2025 —
4 Insider transaction Jul 22, 2025 Jul 21, 2025
4 Insider transaction Jul 18, 2025 Jul 17, 2025
4 Insider transaction Jun 11, 2025 Feb 3, 2025
5 Annual insider ownership Jun 11, 2025 Dec 31, 2024
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Jan 30, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Dec 31, 2024 Dec 30, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
4 Insider transaction Dec 26, 2024 Dec 24, 2024
4 Insider transaction Dec 26, 2024 Dec 24, 2024
4 Insider transaction Dec 26, 2024 Dec 24, 2024
144 Notice of proposed sale Dec 23, 2024 —
144 Notice of proposed sale Dec 23, 2024 —
144 Notice of proposed sale Dec 23, 2024 —
4 Insider transaction Oct 23, 2024 Oct 23, 2024
4 Insider transaction Oct 17, 2024 Oct 17, 2024
4 Insider transaction Oct 16, 2024 Oct 16, 2024
144 Notice of proposed sale Oct 4, 2024 —
4 Insider transaction Aug 26, 2024 Aug 22, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
3 Initial insider ownership Aug 5, 2024 Aug 2, 2024
4/A Filing Jul 23, 2024 Jul 22, 2024
4 Insider transaction Jul 23, 2024 Jul 22, 2024
4 Insider transaction Jun 20, 2024 Jun 20, 2024
4 Insider transaction Apr 30, 2024 Apr 30, 2024
4 Insider transaction Apr 25, 2024 Apr 24, 2024
5 Annual insider ownership Apr 25, 2024 Dec 31, 2023
4 Insider transaction Apr 25, 2024 Apr 22, 2024
4 Insider transaction Apr 22, 2024 Apr 22, 2024
4 Insider transaction Apr 9, 2024 Apr 9, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
3 Initial insider ownership Feb 16, 2024 Dec 7, 2023
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Feb 7, 2024 Jan 24, 2024
4 Insider transaction Jan 16, 2024 Jan 16, 2024
4 Insider transaction Jan 2, 2024 Dec 29, 2023
4 Insider transaction Dec 18, 2023 Dec 15, 2023
5 Annual insider ownership Dec 1, 2023 Jan 12, 2022
SC 13D/A Amended ownership over 5% (active) Dec 1, 2023 —
4 Insider transaction Dec 1, 2023 Nov 30, 2023
4 Insider transaction Nov 15, 2023 Nov 15, 2023
4 Insider transaction Oct 31, 2023 Oct 31, 2023
4/A Filing Oct 16, 2023 Oct 13, 2023
4 Insider transaction Oct 16, 2023 Oct 13, 2023
4 Insider transaction Oct 2, 2023 Sep 29, 2023
4 Insider transaction Sep 27, 2023 Sep 26, 2023
4 Insider transaction Sep 18, 2023 Sep 15, 2023
144 Notice of proposed sale Sep 11, 2023 —
4 Insider transaction Sep 1, 2023 Aug 31, 2023
4 Insider transaction Aug 15, 2023 Aug 15, 2023
4 Insider transaction Jul 31, 2023 Jul 31, 2023
4 Insider transaction Jul 20, 2023 Jul 19, 2023
4 Insider transaction Jul 17, 2023 Jul 14, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jun 16, 2023 Jun 15, 2023
4 Insider transaction Jun 1, 2023 May 31, 2023
4 Insider transaction May 16, 2023 May 15, 2023
4 Insider transaction May 9, 2023 Apr 28, 2023
4 Insider transaction Apr 17, 2023 Apr 14, 2023
4 Insider transaction Apr 3, 2023 Mar 31, 2023
4 Insider transaction Mar 16, 2023 Mar 15, 2023
4 Insider transaction Mar 2, 2023 Feb 28, 2023
4 Insider transaction Feb 21, 2023 Feb 21, 2023
4 Insider transaction Feb 21, 2023 Feb 16, 2023
4 Insider transaction Feb 15, 2023 Feb 15, 2023
4 Insider transaction Feb 7, 2023 Feb 7, 2023
4 Insider transaction Jan 31, 2023 Jan 31, 2023
5 Annual insider ownership Jan 31, 2023 Dec 31, 2022
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 26, 2023 Jan 25, 2023
4 Insider transaction Jan 17, 2023 Jan 13, 2023
4 Insider transaction Jan 3, 2023 Dec 30, 2022
4 Insider transaction Dec 15, 2022 Dec 15, 2022
4 Insider transaction Dec 1, 2022 Nov 30, 2022
4 Insider transaction Nov 17, 2022 Nov 17, 2022
4 Insider transaction Nov 15, 2022 Nov 15, 2022
4 Insider transaction Nov 1, 2022 Oct 31, 2022
4 Insider transaction Oct 31, 2022 Oct 28, 2022
4 Insider transaction Oct 17, 2022 Oct 14, 2022
4/A Filing Oct 3, 2022 Sep 30, 2022
4 Insider transaction Oct 3, 2022 Sep 30, 2022
4 Insider transaction Sep 15, 2022 Sep 15, 2022
4 Insider transaction Sep 1, 2022 Aug 31, 2022
4 Insider transaction Aug 15, 2022 Aug 15, 2022
4/A Filing Aug 15, 2022 Jul 27, 2022
4 Insider transaction Aug 9, 2022 Jul 22, 2022
4/A Filing Aug 1, 2022 Jul 29, 2022
4 Insider transaction Aug 1, 2022 Jul 29, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GALT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Norcross, GA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1133416
Former names
PRO PHARMACEUTICALS INC (until May 26, 2011)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.